First Tracks Biotherapeutics Inc

TRAX | NASDAQ

$45.99

+$0.91 (+2.02%)

Nov 2, 2026, 9:52 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
PE Ratio	-3.98	-4.03	-6.23
PEG Ratio	n/a	0.04	n/a
PS Ratio	n/a	n/a	n/a
PB Ratio	2.30	1.69	1.61
P/FCF Ratio	-4.62	-5.23	-7.04
P/OCF Ratio	-4.62	-5.25	-7.10
OCF/S Ratio	n/a	n/a	n/a
Debt / Equity Ratio	0.05	0.04	0.04
Quick Ratio	10.20	10.78	21.87
Current Ratio	10.20	10.78	21.87
Asset Turnover	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a
Return on Equity	-57.77%	-41.80%	-25.90%
Return on Assets	-50.25%	-37.05%	-23.90%
Return on Invested Capital	-59.35%	-44.43%	-27.70%
Dividend Yield	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a